October 22, 2021
Photo Courtesy of NanoCellect
The proceeds from NanoCellect’s $35 million funding rounds will support the development and launch of its second-generation WOLF G2 cell sorting system.
Stories this photo appears in:
BIOTECH: Local Investors Back Co.
NanoCellect Biomedical, Inc. brought in $35 million in Series C and D funding to advance its microfluidic cell sorting solutions. Local investors such as FusionX Ventures, Anzu Partners and Agilent Technologies are among those backing the San Diego biotech.